Last updated September 2023 - Hadassah Medical Center
1.
Farfara D, Sooliman M, Avrahami L, Royal TG, Amram S, Rozenstein-Tsalkovich L, et al. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice. Journal of Neuroinflammation [Internet]. 2023;20(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85165708045&doi=10.1186%252fs12974-023-02823-9&partnerID=40&md5=24dd11aa42e9aa692f1d5d8ddbd191b3
2.
Balash Y, Kahana E, Korczyn AD, Wolker M, Nabal H, Anis E, et al. Is There Horizontal Transmission of Creutzfeldt-Jakob Disease? Neuroepidemiology [Internet]. 2023;57(3):156–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85168428363&doi=10.1159%252f000530407&partnerID=40&md5=99cd7dac3862ead95394908b61889ecc
3.
Sweetat S, Nitzan K, Suissa N, Haimovich Y, Lichtenstein M, Zabit S, et al. The Beneficial Effect of Mitochondrial Transfer Therapy in 5XFAD Mice via Liver–Serum–Brain Response. Cells [Internet]. 2023;12(7). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85152343015&doi=10.3390%252fcells12071006&partnerID=40&md5=1ee1606a18c9fbdada876e99d8018d61
4.
Safadi D, Cohen OS, Chapman J, Rosenmann H, Nitsan Z, Kahan E, et al. The epidemiological and clinical characteristics of patients with young-onset genetic Creutzfeldt-Jakob disease. Neurological Research [Internet]. 2023;45(9):854–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85159117143&doi=10.1080%252f01616412.2023.2212210&partnerID=40&md5=e24fcd2ddcb61f328d7a681580d6fab7
5.
Menendez L, Milo R, Cohen OS, Chapman J, Rosenmann H, Nitsan Z, et al. Genetic Creutzfeldt-Jakob disease in Turkish Jews—demographic and clinical features. Acta Neurologica Scandinavica [Internet]. 2022;146(5):586–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135913638&doi=10.1111%252fane.13684&partnerID=40&md5=bad7f44ea32b97ea10d6b108a222baee
6.
Samuel I, Ben-Haroush Schyr R, Arad Y, Attali T, Azulai S, Bergel M, et al. Sleeve Gastrectomy Reduces Glycemia but Does Not Affect Cognitive Impairment in Lean 5xFAD Mice. Frontiers in Neuroscience [Internet]. 2022;16. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136587353&doi=10.3389%252ffnins.2022.937663&partnerID=40&md5=2537ad9780aa54786d5d859da0979f95
7.
Trachtenbroit I, Cohen OS, Chapman J, Rosenmann H, Nitsan Z, Kahana E, et al. Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease. Neurological Sciences [Internet]. 2022;43(7):4275–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125814786&doi=10.1007%252fs10072-022-05929-9&partnerID=40&md5=1d5253793afd9f6bd8fa129314b721fe
8.
Kakhlon O, Vaknin H, Mishra K, D’Souza J, Marisat M, Sprecher U, et al. Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism. EMBO Molecular Medicine [Internet]. 2021;13(10). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114367015&doi=10.15252%252femmm.202114554&partnerID=40&md5=e12eb653327ab48edc5cf3272e3f5e42
9.
Appel S, Cohen OS, Chapman J, Gilat S, Rosenmann H, Nitsan Z, et al. Spatial distribution of abnormal EEG activity in Creutzfeldt-Jakob disease. Neurophysiologie Clinique [Internet]. 2021;51(3):219–24. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103400642&doi=10.1016%252fj.neucli.2021.02.004&partnerID=40&md5=54bf44b187e4332e9cf25156540f1b86
10.
Binyamin O, Nitzan K, Frid K, Ungar Y, Rosenmann H, Gabizon R. Author Correction: Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice (Scientific Reports, (2019), 9, 1, (18437), 10.1038/s41598-019-54971-9). Scientific Reports [Internet]. 2020;10(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078192471&doi=10.1038%252fs41598-020-58232-y&partnerID=40&md5=89f028f9cacd7baf782e522a40532d19
11.
Nitsan Z, Cohen OS, Chapman J, Kahana E, Korczyn AD, Appel S, et al. Familial Creutzfeldt–Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course. Journal of Neurology [Internet]. 2020;267(8):2455–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085089127&doi=10.1007%252fs00415-020-09826-z&partnerID=40&md5=85d1a6b6bb07a62ca7ae8dc1e507b309
12.
Cohen OS, Kahana E, Korczyn AD, Ziv-Baran T, Nitsan Z, Appel S, et al. Pseudo-anticipation in Creutzfeldt–Jakob disease is due to a rhomboid-shaped artifact. European Journal of Neurology [Internet]. 2020;27(4):596–602. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078819069&doi=10.1111%252fene.14138&partnerID=40&md5=59f5a6f429210b40d20490586f5b9cbd
13.
Lahiani-Cohen I, Touloumi O, Lagoudaki R, Grigoriadis N, Rosenmann H. Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice. Frontiers in Cell and Developmental Biology [Internet]. 2020;7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078724932&doi=10.3389%252ffcell.2019.00321&partnerID=40&md5=9672e7633ca4fb9250a3254b03a649d2
14.
Benhamron S, Nitzan K, Valitsky M, Lax N, Karussis D, Kassis I, et al. Cerebrospinal Fluid (CSF) Exchange Therapy with Artificial CSF Enriched with Mesenchymal Stem Cell Secretions Ameliorates Cognitive Deficits and Brain Pathology in Alzheimer’s Disease Mice. Journal of Alzheimer’s Disease [Internet]. 2020;76(1):369–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087533655&doi=10.3233%252fJAD-191219&partnerID=40&md5=a612d71725aeec805dea64691358115b
15.
Binyamin O, Nitzan K, Frid K, Ungar Y, Rosenmann H, Gabizon R. Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice. Scientific Reports [Internet]. 2019;9(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076054200&doi=10.1038%252fs41598-019-54971-9&partnerID=40&md5=d0a3aa4173a226b030a26859a3454a27
16.
Appel S, Cohen OS, Chapman J, Gilat S, Rosenmann H, Nitsan Z, et al. The association of quantitative EEG and MRI in Creutzfeldt-Jakob Disease. Acta Neurologica Scandinavica [Internet]. 2019;140(5):366–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071948297&doi=10.1111%252fane.13154&partnerID=40&md5=c64686ebad8a25d27d6ff1a64a537b1e
17.
Cohen OS, Chapman J, Korczyn AD, Nitsan Z, Appel S, Kahana E, et al. Disease duration in E200K familial Creutzfeldt–Jakob disease is correlated with clinical, radiological, and laboratory variables. Journal of Neural Transmission [Internet]. 2019;126(5):607–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057585382&doi=10.1007%252fs00702-018-1958-1&partnerID=40&md5=c76c5f4e083184688550a5771dd82af7
18.
Valitsky M, Benhamron S, Nitzan K, Karussis D, Ella E, Abramsky O, et al. Cerebrospinal fluid (CSF) exchange with artificial csf enriched with mesenchymal stem cell secretions ameliorates experimental autoimmune encephalomyelitis. International Journal of Molecular Sciences [Internet]. 2019;20(7). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064828070&doi=10.3390%252fijms20071793&partnerID=40&md5=f279b3c3f1089de2d61191bc4f412530
19.
Nitzan K, Benhamron S, Valitsky M, Kesner EE, Lichtenstein M, Ben-Zvi A, et al. Mitochondrial Transfer Ameliorates Cognitive Deficits, Neuronal Loss, and Gliosis in Alzheimer’s Disease Mice. Journal of Alzheimer’s disease : JAD [Internet]. 2019;72(2):587–604. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075812542&doi=10.3233%252fJAD-190853&partnerID=40&md5=2b4b969bdbd98efcb1dddabc2cd36955
20.
Benhamron S, Rozenstein-Tsalkovich L, Nitzan K, Abramsky O, Rosenmann H. Phos-tau peptide immunization of amyloid-tg-mice reduced non-mutant phos-tau pathology, improved cognition and reduced amyloid plaques. Experimental Neurology [Internet]. 2018;303:48–58. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041806963&doi=10.1016%252fj.expneurol.2018.02.004&partnerID=40&md5=f3a4ae3487190f440ecfd473ffd8637d
21.
Cohen OS, Chapman J, Korczyn AD, Siaw OL, Warman-Alaluf N, Nitsan Z, et al. Clinical radiological correlation in E200K familial Creutzfeldt–Jakob disease. Journal of Neural Transmission [Internet]. 2016;123(12):1457–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84987624264&doi=10.1007%252fs00702-016-1617-3&partnerID=40&md5=93adefbb5eb2f86616cfbb1558109b8e
22.
Cohen OS, Chapman J, Korczyn AD, Siaw OL, Warman-Alaluf N, Nitsan Z, et al. CSF tau correlates with the degree of cortical involvement in E200K familial Creutzfeldt-Jakob disease. Neuroscience Letters [Internet]. 2016;634:76–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991444239&doi=10.1016%252fj.neulet.2016.10.012&partnerID=40&md5=30287f9daf9363dff48019578ed06ed7
23.
Cohen OS, Kimiagar I, Korczyn AD, Nitsan Z, Appel S, Hoffmann C, et al. Unusual presentations in patients with E200K familial Creutzfeldt-Jakob disease. European Journal of Neurology [Internet]. 2016;23(5):871–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956655468&doi=10.1111%252fene.12955&partnerID=40&md5=c7a6210ee432731cd4d339019a5304fa
24.
Cohen OS, Chapman J, Korczyn AD, Warman-Alaluf N, Nitsan Z, Appel S, et al. CSF tau correlates with CJD disease severity and cognitive decline. Acta Neurologica Scandinavica [Internet]. 2016;133(2):119–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953635630&doi=10.1111%252fane.12441&partnerID=40&md5=c3d42460b6a1d8d67a9dfa9eb744943b
25.
Hellmann MA, Kakhlon O, Landau EH, Sadeh M, Giladi N, Schlesinger I, et al. Frequent misdiagnosis of adult polyglucosan body disease. Journal of Neurology [Internet]. 2015;262(10):2346–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84944511301&doi=10.1007%252fs00415-015-7859-4&partnerID=40&md5=e784ae6d086a3aaa8debdf417eb573e6
26.
Orhan Akman H, Kakhlon O, Coku J, Peverelli L, Rosenmann H, Rozenstein-Tsalkovich L, et al. Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease. JAMA Neurology [Internet]. 2015;72(4):441–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928104305&doi=10.1001%252fjamaneurol.2014.4496&partnerID=40&md5=97b00ec1b09dbe7472d1cc852c4eacd4
27.
Cohen OS, Chapman J, Korczyn AD, Nitsan Z, Appel S, Hoffmann C, et al. Familial Creutzfeldt–Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD. Journal of Neurology [Internet]. 2015;262(3):604–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925538957&doi=10.1007%252fs00415-014-7615-1&partnerID=40&md5=5c0fa9c20be7b0babdc4b8c33f94808b
28.
Appel S, Chapman J, Cohen OS, Rosenmann H, Nitsan Z, Blatt I. Seizures in E200K familial and sporadic Creutzfeldt-Jakob disease. Acta Neurologica Scandinavica [Internet]. 2015;131(3):152–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938538099&doi=10.1111%252fane.12304&partnerID=40&md5=b942c130f66fb57599de65a4dc45a518
29.
Cohen OS, Chapman J, Korczyn AD, Warman-Alaluf N, Orlev Y, Givaty G, et al. Characterization of sleep disorders in patients with E200K familial Creutzfeldt–Jakob disease. Journal of Neurology [Internet]. 2015;262(2):443–50. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925504052&doi=10.1007%252fs00415-014-7593-3&partnerID=40&md5=91b8b289155d02ec7cd77f15c5087f7d
30.
Mattsson N, Andreasson U, Persson S, Carrillo MC, Collins S, Chalbot S, et al. Erratum: CSF biomarker variability in the Alzheimer’s Association quality control program (Alzheimer’s and Dementia (2013) 9 (251-261)). Alzheimer’s and Dementia [Internet]. 2015;11(2):237. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84933531907&doi=10.1016%252fj.jalz.2014.12.004&partnerID=40&md5=dfa2bd174a5faf35aa4fe8befedcea7e
31.
Gotkine M, Rozenstein L, Einstein O, Abramsky O, Argov Z, Rosenmann H. Erratum: Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice (BioMed Research International). BioMed Research International [Internet]. 2015;2015. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924419648&doi=10.1155%252f2015%252f651934&partnerID=40&md5=053762c8b7b0609f5560bd5c48e3957b
32.
Jiang T, Chang RCC, Rosenmann H, Yu JT. Advances in Alzheimer’s disease: From bench to bedside. BioMed Research International [Internet]. 2015;2015. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924309920&doi=10.1155%252f2015%252f202676&partnerID=40&md5=028489389f14329917cbb9da578edfd0
33.
Rosenmann H. Asparagine endopeptidase cleaves tau and promotes neurodegeneration. Nature Medicine [Internet]. 2014;20(11):1236–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922392905&doi=10.1038%252fnm.3749&partnerID=40&md5=4c6c9923cf60489f885d07fb3790cb67
34.
Rozenstein-Tsalkovich L, Grigoriadis N, Lourbopoulos A, Nousiopoulou E, Kassis I, Abramsky O, et al. Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation. Experimental Neurology [Internet]. 2013;248:451–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84882793431&doi=10.1016%252fj.expneurol.2013.07.006&partnerID=40&md5=a57611d8b261328de412bc2b4049a69c
35.
Boimel M, Grigoriadis N, Lourbopoulos A, Haber E, Abramsky O, Rosenmann H. Corrigendum to “Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice” [Exp. Neurol. 224/2 (2010) 472-485]. Experimental Neurology [Internet]. 2013;247:8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890681215&doi=10.1016%252fj.expneurol.2013.03.013&partnerID=40&md5=e6fc62f2fe3d4d9f30e76216dcde2b8e
36.
Rosenmann H. Immunotherapy for targeting tau pathology in Alzheimer’s disease and tauopathies. Current Alzheimer Research [Internet]. 2013;10(3):217–28. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876873579&doi=10.2174%252f1567205011310030001&partnerID=40&md5=ae7d20bc4f488f8067151e993652e99d
37.
Mattsson N, Andreasson U, Persson S, Carrillo MC, Collins S, Chalbot S, et al. CSF biomarker variability in the Alzheimer’s Association quality control program. Alzheimer’s and Dementia [Internet]. 2013;9(3):251–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876909712&doi=10.1016%252fj.jalz.2013.01.010&partnerID=40&md5=1417adf31be90e669ddd9c8a9dccadf6
38.
Marc G, Leah R, Ofira E, Oded A, Zohar A, Hanna R. Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice. BioMed Research International [Internet]. 2013;2013. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896084932&doi=10.1155%252f2013%252f845345&partnerID=40&md5=83dda087f3e7657a75e1dca559493389
39.
Rosenmann H, Meiner Z. [Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment]. Harefuah [Internet]. 2013;152(11):661–6, 687. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893594574&partnerID=40&md5=add23d85430d21ee3967813bcdc50fc7
40.
Lee H, Cohen OS, Rosenmann H, Hoffmann C, Kingsley PB, Korczyn AD, et al. Cerebral white matter disruption in Creutzfeldt-Jakob disease. American Journal of Neuroradiology [Internet]. 2012;33(10):1945–50. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870950601&doi=10.3174%252fajnr.A3125&partnerID=40&md5=cb30c769bd97c910e20b4acf999a1f6b
41.
Rosenmann H, Blum D, Kayed R, Ittner LM. Tau protein: Function and pathology. International Journal of Alzheimer’s Disease [Internet]. 2012; Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866262430&doi=10.1155%252f2012%252f707482&partnerID=40&md5=f46fdc4a33c6b5416ba05b3349443220
42.
Mochel F, Schiffmann R, Steenweg ME, Akman HO, Wallace M, Sedel F, et al. Adult polyglucosan body disease: Natural history and key magnetic resonance imaging findings. Annals of Neurology [Internet]. 2012;72(3):433–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867081423&doi=10.1002%252fana.23598&partnerID=40&md5=866c365bc129f02b7a75ed685f423a98
43.
Rosenmann H. CSF biomarkers for amyloid and tau pathology in Alzheimer’s disease. Journal of Molecular Neuroscience [Internet]. 2012;47(1):1–14. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859712858&doi=10.1007%252fs12031-011-9665-5&partnerID=40&md5=bd9725c0a718db903e796bdf6d5d44ed
44.
Cohen OS, Prohovnik I, Korczyn AD, Inzelberg R, Nitsan Z, Appel S, et al. Characterization of movement disorders in patients with familial creutzfeldt-jakob disease carrying the E200K mutation. Israel Medical Association Journal [Internet]. 2012;14(3):162–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859061213&partnerID=40&md5=006d84cb878aed80de1e91862f2986bf
45.
Meiner Z, Rosenmann H. [Biological markers in the diagnosis of dementia and Alzheimer’s disease]. Harefuah [Internet]. 2012;151(5):289–93, 318. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865607175&partnerID=40&md5=c536f051cb4da004df9c782a2118c989
46.
Cohen OS, Prohovnik I, Korczyn AD, Ephraty L, Nitsan Z, Tsabari R, et al. The Creutzfeldt-Jakob disease (CJD) neurological status scale: A new tool for evaluation of disease severity and progression. Acta Neurologica Scandinavica [Internet]. 2011;124(6):368–74. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054908380&doi=10.1111%252fj.1600-0404.2011.01489.x&partnerID=40&md5=9d909ce2b157cef4728bb9cacc1b0b08
47.
Lahiani-Cohen I, Lourbopoulos A, Haber E, Rozenstein-Tsalkovich L, Abramsky O, Grigoriadis N, et al. Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model. Journal of Neuropathology and Experimental Neurology [Internet]. 2011;70(7):610–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959529114&doi=10.1097%252fNEN.0b013e318221bfab&partnerID=40&md5=62ca552cbbce57c9d5a167fe9e02e33c
48.
Ginsburg I, Rozenstein-Tsalkovich L, Koren E, Rosenmann H. The herbal preparation padma® 28 protects against neurotoxicity in PC12 cells. Phytotherapy Research [Internet]. 2011;25(5):740–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955538788&doi=10.1002%252fptr.3459&partnerID=40&md5=f132f4c68e1cdc9895559a218cc5b90d
49.
Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, et al. Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. Journal of Neurology [Internet]. 2011;258(2):255–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953798376&doi=10.1007%252fs00415-010-5738-6&partnerID=40&md5=33833fe09e74117b83b5bf0126bad13b
50.
Cohen OS, Chapman J, Lee H, Nitsan Z, Appel S, Hoffman C, et al. Pruritus in familial Creutzfeldt-Jakob disease: A common symptom associated with central nervous system pathology. Journal of Neurology [Internet]. 2011;258(1):89–95. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78751647991&doi=10.1007%252fs00415-010-5694-1&partnerID=40&md5=17ce2b32b41335d42155687daebff5f9
51.
Boimel M, Grigoriadis N, Lourbopoulos A, Haber E, Abramsky O, Rosenmann H. Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice. Experimental Neurology [Internet]. 2010;224(2):472–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954656871&doi=10.1016%252fj.expneurol.2010.05.010&partnerID=40&md5=2dc632da0c5f9218d8f980d81c18570e
52.
Appel SA, Chapman J, Kahana E, Rosenmann H, Prohovnik I, Pras E, et al. Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever. European Journal of Neurology [Internet]. 2010;17(6):861–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952469576&doi=10.1111%252fj.1468-1331.2010.02948.x&partnerID=40&md5=7f57f6870a7c69d78244b8f53335c193
53.
Shiryaev N, Jouroukhin Y, Giladi E, Polyzoidou E, Grigoriadis NC, Rosenmann H, et al. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model. Neurobiology of Disease [Internet]. 2009;34(2):381–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-64649097649&doi=10.1016%252fj.nbd.2009.02.011&partnerID=40&md5=ec3558e45c5a4ddd084b181b90c31a2e
54.
Boimel M, Grigoriadis N, Lourbopoulos A, Touloumi O, Rosenmann D, Abramsky O, et al. Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. Journal of Neuropathology and Experimental Neurology [Internet]. 2009;68(3):314–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-65349152565&doi=10.1097%252fNEN.0b013e31819ac3cb&partnerID=40&md5=1a69eb13fd4348811fa4f6142beb359e
55.
Lee H, Rosenmann H, Chapman J, Kingsley PB, Hoffmann C, Cohen OS, et al. Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain [Internet]. 2009;132(10):2680–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349959806&doi=10.1093%252fbrain%252fawp064&partnerID=40&md5=64bd1bc042150197e58130a9b61a569d
56.
Dresner-Pollak R, Kinnar T, Friedlander Y, Sharon N, Rosenmann H, Pollak A. Estrogen receptor beta gene variant is associated with vascular dementia in elderly women. Genetic testing and molecular biomarkers [Internet]. 2009;13(3):339–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651046926&doi=10.1089%252fgtmb.2008.0129&partnerID=40&md5=d06653416c05403aa696947342206180
57.
Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, et al. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Experimental Neurology [Internet]. 2008;212(1):71–84. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-44949185340&doi=10.1016%252fj.expneurol.2008.03.007&partnerID=40&md5=45b870fa1d0b2d3ee73b3428eedcd15f
58.
Rosenmann H, Meiner Z, Geylis V, Abramsky O, Steinitz M. Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer’s disease and healthy subjects. Neuroscience Letters [Internet]. 2006;410(2):90–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750681275&doi=10.1016%252fj.neulet.2006.01.072&partnerID=40&md5=920e12d03e7b36454807ef0f35a2a0f3
59.
Rosenmann H, Grigoriadis N, Karussis D, Boimel M, Touloumi O, Ovadia H, et al. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Archives of Neurology [Internet]. 2006;63(10):1459–67. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749614555&doi=10.1001%252farchneur.63.10.1459&partnerID=40&md5=0be27e9780aa4cbf25c914b97124509b
60.
Meiner V, Weinberg N, Safran A, Israela L, Sagi M, Rosenmann H, et al. Preimplantation exclusion of embryos at risk for prion diseases. Neurology [Internet]. 2006;66(4):607–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645011827&doi=10.1212%252f01.WNL.0000197984.03391.9B&partnerID=40&md5=89e20e9d5a05d29cd23da147a9a5fd66
61.
Lossos A, Khoury M, Rizzo WB, Gomori JM, Banin E, Zlotogorski A, et al. Phenotypic variability among adult siblings with Sjögren-Larsson syndrome. Archives of Neurology [Internet]. 2006;63(2):278–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-32944462854&doi=10.1001%252farchneur.63.2.278&partnerID=40&md5=8f33c68ed3901c52f90493eeaa15973c
62.
Lossos A, Soffer D, Steiner-Birmanns B, Hassin-Baer S, Sadeh M, Sagi M, et al. Extended phenotype in the transthyretin Tyr77 familial amyloid polyneuropathy. European Neurology [Internet]. 2005;53(2):55–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-20544433664&doi=10.1159%252f000084299&partnerID=40&md5=66e591bd2833b92d1f67b3ba2a5c53f8
63.
Rosenmann H, Meiner Z, Kahana E, Aladjem Z, Friedman G, Ben-Yehuda A, et al. An association study of a polymorphism in the heparan sulfate proteoglycan gene (perlecan, HSPG2) and Alzheimer’s disease. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2004;128 B(1):123–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-3042810125&doi=10.1002%252fajmg.b.30015&partnerID=40&md5=78f189628e3f083f8cf9e53d393a9990
64.
Rosenmann H, Meiner Z, Dresner-Pollak R, Kahana E, Aladjem Z, Grenader T, et al. Lack of association of interleukin-1beta polymorphism with Alzheimer’s disease in the Jewish population. Neuroscience Letters [Internet]. 2004;363(2):131–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-2542477002&doi=10.1016%252fj.neulet.2004.03.063&partnerID=40&md5=c0b77172d69ad8dddc32ac499193b289
65.
Rosenmann H, Meiner Z, Kahana E, Aladjem Z, Friedman G, Ben-Yehuda A, et al. The fas promoter polymorphism at position -670 is not associated with late-onset sporadic Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders [Internet]. 2004;17(3):143–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542405251&doi=10.1159%252f000076347&partnerID=40&md5=6a3144cb1f09a84361d8d81af1501297
66.
Hijazi N, Shaked Y, Rosenmann H, Ben-Hur T, Gabizon R. Copper binding to PrPC may inhibit prion disease propagation. Brain Research [Internet]. 2003;993(1–2):192–200. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0345714734&doi=10.1016%252fj.brainres.2003.09.014&partnerID=40&md5=2622ff7d5ea1a92ee5f575a173af2a62
67.
Lossos A, Reches A, Gal A, Newman JP, Soffer D, Gomori JM, et al. Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family. Journal of Neurology [Internet]. 2003;250(6):733–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038796582&doi=10.1007%252fs00415-003-1074-4&partnerID=40&md5=cdd52b7f772db0013f140bc293efcd79
68.
Rosenmann H, Meiner Z, Kahana E, Aladjem Z, Friedman G, Ben-Yehuda A, et al. An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer’s disease. Neuroscience Letters [Internet]. 2003;340(1):29–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037417176&doi=10.1016%2fS0304-3940%2803%2900049-1&partnerID=40&md5=9218d5c0cf70478d403fd82b09ae708e
69.
Rosenmann H, Meiner Z, Kahana E, Aladjem Z, Friedman G, Ben-Yehuda A, et al. A polymorphism in the complement component C1r is not associated with sporadic Alzheimer’s disease. Neuroscience Letters [Internet]. 2003;336(2):101–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037448312&doi=10.1016%2fS0304-3940%2802%2901218-1&partnerID=40&md5=b6d85814256e83b9cdd8635f900b691e
70.
Shaked GM, Engelstein R, Avraham I, Rosenmann H, Gabizon R. Valproic acid treatment results in increased accumulation of prion proteins. Annals of Neurology [Internet]. 2002;52(4):416–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036791879&doi=10.1002%252fana.10298&partnerID=40&md5=10176a73c845ee3d1e4592105ea843cb
71.
Shaked Y, Rosenmann H, Hijazi N, Halimi M, Gabizon R. Copper binding to the PrP isoforms: A putative marker of their conformation and function. Journal of Virology [Internet]. 2001;75(17):7872–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034869272&doi=10.1128%252fJVI.75.17.7872-7874.2001&partnerID=40&md5=2d4d876af66b8f21a636a4a3a4babb78
72.
Rosenmann H, Talmor G, Halimi M, Yanai A, Gabizon R, Meiner Z. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrPC. Journal of Neurochemistry [Internet]. 2001;76(6):1654–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035100183&doi=10.1046%252fj.1471-4159.2001.00195.x&partnerID=40&md5=d2c88fa688c2d078ce6caa387fc13189
73.
McNally EM, Ly T, Rosenmann H, Rosenbaum SM, Jiang W, Anderson LVB, et al. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. American Journal of Medical Genetics [Internet]. 2000;91(4):305–12. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034709195&doi=10.1002%2f%28SICI%291096-8628%2820000410%2991%3a4%3c305%3a%3aAID-AJMG12%3e3.0.CO%3b2-S&partnerID=40&md5=d6409daae2ee03b4ce65561b92485cdc
74.
Simon ES, Kahana E, Chapman J, Treves TA, Gabizon R, Rosenmann H, et al. Creutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200k mutation. Annals of Neurology [Internet]. 2000;47(2):257–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033966706&doi=10.1002%2f1531-8249%28200002%2947%3a2%3c257%3a%3aAID-ANA20%3e3.0.CO%3b2-U&partnerID=40&md5=47374bc9766c664588d65aa2d3e9ba4f
75.
Argov Z, Sadeh M, Mazor K, Soffer D, Kahana E, Eisenberg I, et al. Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features. Brain [Internet]. 2000;123(6):1229–37. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034122879&doi=10.1093%252fbrain%252f123.6.1229&partnerID=40&md5=b5da68bb8bb55418f88b8cacc22a0d56
76.
Shaked Y, Rosenmann H, Talmor G, Gabizon R. A C-terminal-truncated PrP isoform is present in mature sperm. Journal of Biological Chemistry [Internet]. 1999;274(45):32153–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033527644&doi=10.1074%252fjbc.274.45.32153&partnerID=40&md5=aed03afd31adea1a778c9e9ddbf6cf80
77.
Rosenmann H, Kahana E, Korczyn AD, Kahana I, Chapman J, Gabizon R. Preliminary evidence for anticipation in genetic E200K Creutzfeldt-Jakob disease. Neurology [Internet]. 1999;53(6):1328–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032852301&doi=10.1212%252fwnl.53.6.1328&partnerID=40&md5=db5083889d50aaaa97fc947f8d7689b1
78.
Rosenmann H, Vardi J, Finkelstein Y, Chapman J, Gabizon R. Identification in Israel of 2 Jewish Creutzfeldt-Jakob disease patients with a 178 mutation at their PrP gene. Acta Neurologica Scandinavica [Internet]. 1998;97(3):184–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031802443&doi=10.1111%252fj.1600-0404.1998.tb00634.x&partnerID=40&md5=4491de2bc8cf21ed112b0ac63ebc7823
79.
Rosenmann H, Halimi M, Kahana I, Biran I, Gabizon R. Differential allelic expression of PrP mRNA in carriers of the E200K mutation. Neurology [Internet]. 1997;49(3):851–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030774622&doi=10.1212%252fWNL.49.3.851&partnerID=40&md5=b385e0567482487b58df8effbaf6d783
80.
Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O, et al. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt Jakob disease. Neurology [Internet]. 1997;49(2):593–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030766643&doi=10.1212%252fWNL.49.2.593&partnerID=40&md5=6d5ee78ab675605cd42c0ac4fa9bfcc9
81.
Ovadia H, Rosenmann H, Shezen E, Halimi M, Ofran I, Gabizon R. Effect of scrapie infection on the activity of neuronal nitric-oxide synthase in brain and neuroblastoma cells. Journal of Biological Chemistry [Internet]. 1996;271(28):16856–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030008814&doi=10.1074%252fjbc.271.28.16856&partnerID=40&md5=a6fb075347b2a67cc3d7a1a5cffd27e7
82.
Spudich S, Mastrianni JA, Wrensch M, Gabizon R, Meiner Z, Kahana I, et al. Complete penetrance of Cruetzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Molecular Medicine [Internet]. 1995;1(6):607–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028981199&doi=10.1007%252fbf03401601&partnerID=40&md5=dc972bec5f336973f9d8be68257d6ba6
83.
Gabizon R, Rosenmann H, Meiner Z, Kahana I, Kahana E, Shugart Y, et al. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). American Journal of Human Genetics [Internet]. 1993;53(4):828–35. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027373649&partnerID=40&md5=70a6bf292df7a34c9a492f271d56e8bb